These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 38217526)
21. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe. Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623 [TBL] [Abstract][Full Text] [Related]
22. Platelet membrane-cloaked selenium/ginsenoside Rb1 nanosystem as biomimetic reactor for atherosclerosis therapy. Yin M; Lin J; Yang M; Li C; Wu P; Zou J; Jiang Y; Shao J Colloids Surf B Biointerfaces; 2022 Jun; 214():112464. PubMed ID: 35334311 [TBL] [Abstract][Full Text] [Related]
23. Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration. van der Valk FM; van Wijk DF; Lobatto ME; Verberne HJ; Storm G; Willems MC; Legemate DA; Nederveen AJ; Calcagno C; Mani V; Ramachandran S; Paridaans MP; Otten MJ; Dallinga-Thie GM; Fayad ZA; Nieuwdorp M; Schulte DM; Metselaar JM; Mulder WJ; Stroes ES Nanomedicine; 2015 Jul; 11(5):1039-46. PubMed ID: 25791806 [TBL] [Abstract][Full Text] [Related]
24. Treatment of atherosclerotic plaque: perspectives on theranostics. Zhang Y; Koradia A; Kamato D; Popat A; Little PJ; Ta HT J Pharm Pharmacol; 2019 Jul; 71(7):1029-1043. PubMed ID: 31025381 [TBL] [Abstract][Full Text] [Related]
25. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype. Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806 [TBL] [Abstract][Full Text] [Related]
26. Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques? Gelsomino F; Fiorentino M; Zompatori M; Poerio A; Melotti B; Sperandi F; Gargiulo M; Borghi C; Ardizzoni A Ann Oncol; 2018 Jan; 29(1):284-286. PubMed ID: 29106493 [No Abstract] [Full Text] [Related]
27. Unleashing the biomimetic targeting potential of platelet-derived nanocarriers on atherosclerosis. Jan N; Bostanudin MF; Moutraji SA; Kremesh S; Kamal Z; Hanif MF Colloids Surf B Biointerfaces; 2024 Aug; 240():113979. PubMed ID: 38823339 [TBL] [Abstract][Full Text] [Related]
28. Nanotechnology in diagnosis and treatment of coronary artery disease. Karimi M; Zare H; Bakhshian Nik A; Yazdani N; Hamrang M; Mohamed E; Sahandi Zangabad P; Moosavi Basri SM; Bakhtiari L; Hamblin MR Nanomedicine (Lond); 2016; 11(5):513-30. PubMed ID: 26906471 [TBL] [Abstract][Full Text] [Related]
29. Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation. Wu T; Chen X; Wang Y; Xiao H; Peng Y; Lin L; Xia W; Long M; Tao J; Shuai X Nanomedicine; 2018 Oct; 14(7):2215-2226. PubMed ID: 29964220 [TBL] [Abstract][Full Text] [Related]
30. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment. Zhang X; Centurion F; Misra A; Patel S; Gu Z Adv Drug Deliv Rev; 2023 Mar; 194():114709. PubMed ID: 36690300 [TBL] [Abstract][Full Text] [Related]
32. Ultrasound Microbubble Delivery Targeting Intraplaque Neovascularization Inhibits Atherosclerotic Plaque in an APOE-deficient Mouse Model. Yuan H; Hu H; Sun J; Shi M; Yu H; Li C; Sun YU; Yang Z; Hoffman RM In Vivo; 2018; 32(5):1025-1032. PubMed ID: 30150423 [TBL] [Abstract][Full Text] [Related]
33. Targeting macrophages using nanoparticles: a potential therapeutic strategy for atherosclerosis. Zang X; Cheng M; Zhang X; Chen X J Mater Chem B; 2021 Apr; 9(15):3284-3294. PubMed ID: 33881414 [TBL] [Abstract][Full Text] [Related]
34. Effect of Chemically Modified Carbon-Coated Iron Nanoparticles on the Structure of Human Atherosclerotic Plaques Ex Vivo and on Adipose Tissue in Chronic Experiment In Vivo. Akhmedov S; Afanasyev S; Beshchasna N; Trusova M; Stepanov I; Rebenkova M; Poletykina E; Vecherskiy Y; Tverdokhlebov S; Bolbasov E; Balakin S; Opitz J; Yermakov A; Kozlov B Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897812 [TBL] [Abstract][Full Text] [Related]
35. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications. Wang Y; Zhang K; Li T; Maruf A; Qin X; Luo L; Zhong Y; Qiu J; McGinty S; Pontrelli G; Liao X; Wu W; Wang G Theranostics; 2021; 11(1):164-180. PubMed ID: 33391468 [TBL] [Abstract][Full Text] [Related]
36. Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis. Wu C; Mao J; Wang X; Yang R; Wang C; Li C; Zhou X J Nanobiotechnology; 2023 Aug; 21(1):271. PubMed ID: 37592345 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis. Deshpande D; Kethireddy S; Janero DR; Amiji MM PLoS One; 2016; 11(2):e0147337. PubMed ID: 26840601 [TBL] [Abstract][Full Text] [Related]
38. Application of Nanotechnology for Diagnosis and Drug Delivery in Atherosclerosis: A New Horizon of Treatment. Lankala CR; Yasir M; Ishak A; Mekhail M; Kalyankar P; Gupta K Curr Probl Cardiol; 2023 Jun; 48(6):101671. PubMed ID: 36828044 [TBL] [Abstract][Full Text] [Related]
39. Diminazene Aceturate Stabilizes Atherosclerotic Plaque and Attenuates Hepatic Steatosis in apoE-Knockout Mice by Influencing Macrophages Polarization and Taurine Biosynthesis. Stachowicz A; Wiśniewska A; Kuś K; Białas M; Łomnicka M; Totoń-Żurańska J; Kiepura A; Stachyra K; Suski M; Bujak-Giżycka B; Jawień J; Olszanecki R Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070749 [TBL] [Abstract][Full Text] [Related]
40. Recent insights into atherosclerotic plaque cell autophagy. Ni D; Mo Z; Yi G Exp Biol Med (Maywood); 2021 Dec; 246(24):2553-2558. PubMed ID: 34407677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]